The fast pace of AI development in healthcare is raising questions about who will lead the regulatory charge: industry or the government. FDA Commissioner Robert Califf acknowledges the risk of AI outpacing regulation but believes the system will eventually self-correct. He emphasizes the need for shared accountability, particularly urging health systems to take responsibility for potential liabilities associated with AI algorithms.
Meanwhile, pharmaceutical companies like Novo Nordisk are preparing for price negotiations under the Inflation Reduction Act, while innovative startups are pushing the boundaries of AI in healthcare. From Apple Watch's sleep apnea detection to brain-computer interfaces and personalized medicine through RNA editing, AI is transforming the landscape of healthcare
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: physorg_com - 🏆 388. / 55 続きを読む »
ソース: Luxuo - 🏆 571. / 51 続きを読む »